alexa Abstract | Design, synthesis and anticancer activity of novel hybrid compounds of imidazopyridine and quinoline/carbazole

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


A series of novel hybrid compounds of imidazopyridine and quinoline/carbazole derivatives has been prepared and evaluated in vitro against a panel of four human tumor cell lines(viz., cervical HeLa, breast MDA-MB-231, renal ACHN and colon HCT-15). Among them imidazopyridine-quinoline hybrid compounds, 3-(3-benzylimidazo[1,2- a]pyridine-2-yl)-2-chloro-6-methoxyquinoline (8) and 2-chloro-6-methoxy-3-(3-(4-methylbenzylimidazo[1,2- a]pyridine-2-yl)-quinoline (12) showed potent anticancer activity with the IC50 values of(0.34; 0.32; 0.39; 0.31) and (0.35; 0.29; 0.34; 0.30) respectively, 12 being the best among all the compounds synthesized In case of imidazopyridine-carbazole hybrid compounds, 3-(3-benzylimidazo[1,2-a]pyridine-2-yl)-9-ethyl-9H-carbazole(13) showed best activity with the IC50 value of (0.37; 0.41; 0.39; 0.30) followed by compound 9-ethyl-3-(3-4- methylbenzyl)imidazo[1,2-a]pyridine-2-yl)9H-carbazole (17)with the IC50 value of (0.55; 0.49; 0.60; 0.56). This preliminary study discovered that the imidazopyrine scaffold hybridized with quinoline or carbazole could be a good pharmacophore for finding novel and potent anticancer agents.

To read the full article Peer-reviewed Article PDF image

Author(s): Sangeetha Meenakshisundaram Manoj Manickam and Venkateswaran Vinayagam


Hybrid, imidazopyridine, quinoline, carbazole, anticancer activity., anticancer activity

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version